chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Incarcerated hernia, Mental status changes, Sinus arrhythmia
Clinical narrative: Death Narrative: 73 yr old male with a history of CAD, HTN, HFrEF, CKD stage 4, COPD, HCV Cirrhosis and opioid dependence who presented with incarcertated ventral hernia 3 days post OP from ex lap, reduction of SB, closure of hernia primarily. He was off pressors but remained intubated due to poor mental status with unclear etiology. It could be related to liver failure, vs neurological insult vs renal failure. Head CT 4 days prior on the 2/24 were without acute intracranial pathology. Hepatology was consulted and did not believe the liver was the main etiology behind poor mental status. Patient progressively declined with continuously increased IV pressor requirement. ABG showed worsening lactate acidosis and was anuric. Patient's family was notified of decline and agreed for the patient to be transition to comfort care early 2/28. Bedside RN notified pronouncing physician of cessation of respiration and cardiac activity.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal hernia, Anuria, Blood gases abnormal, Death, Endotracheal intubation
Clinical narrative: Death Narrative: 73 yr old male with a history of CAD, HTN, HFrEF, CKD stage 4, COPD, HCV Cirrhosis and opioid dependence who presented with incarcertated ventral hernia 3 days post OP from ex lap, reduction of SB, closure of hernia primarily. He was off pressors but remained intubated due to poor mental status with unclear etiology. It could be related to liver failure, vs neurological insult vs renal failure. Head CT 4 days prior on the 2/24 were without acute intracranial pathology. Hepatology was consulted and did not believe the liver was the main etiology behind poor mental status. Patient progressively declined with continuously increased IV pressor requirement. ABG showed worsening lactate acidosis and was anuric. Patient's family was notified of decline and agreed for the patient to be transition to comfort care early 2/28. Bedside RN notified pronouncing physician of cessation of respiration and cardiac activity.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hepatic failure, Hernia repair, Lactic acidosis, Mental status changes, Neurological symptom
Clinical narrative: Death Narrative: 73 yr old male with a history of CAD, HTN, HFrEF, CKD stage 4, COPD, HCV Cirrhosis and opioid dependence who presented with incarcertated ventral hernia 3 days post OP from ex lap, reduction of SB, closure of hernia primarily. He was off pressors but remained intubated due to poor mental status with unclear etiology. It could be related to liver failure, vs neurological insult vs renal failure. Head CT 4 days prior on the 2/24 were without acute intracranial pathology. Hepatology was consulted and did not believe the liver was the main etiology behind poor mental status. Patient progressively declined with continuously increased IV pressor requirement. ABG showed worsening lactate acidosis and was anuric. Patient's family was notified of decline and agreed for the patient to be transition to comfort care early 2/28. Bedside RN notified pronouncing physician of cessation of respiration and cardiac activity.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Renal failure
Clinical narrative: Death Narrative: 73 yr old male with a history of CAD, HTN, HFrEF, CKD stage 4, COPD, HCV Cirrhosis and opioid dependence who presented with incarcertated ventral hernia 3 days post OP from ex lap, reduction of SB, closure of hernia primarily. He was off pressors but remained intubated due to poor mental status with unclear etiology. It could be related to liver failure, vs neurological insult vs renal failure. Head CT 4 days prior on the 2/24 were without acute intracranial pathology. Hepatology was consulted and did not believe the liver was the main etiology behind poor mental status. Patient progressively declined with continuously increased IV pressor requirement. ABG showed worsening lactate acidosis and was anuric. Patient's family was notified of decline and agreed for the patient to be transition to comfort care early 2/28. Bedside RN notified pronouncing physician of cessation of respiration and cardiac activity.
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Loss of consciousness
Clinical narrative: Patient was vaccinated on 3/12021 with 1st dose Pfizer, lot EN6205 expiration date 6/30/2021. Patient denied medical conditions excpet adverse reaction of seizure after HPV vaccine. Patient informed RN that she had syncopal episode at 15min and 25min after receiving the 1st dose. Her vital signs were within normal limits after. Patient denied allergies. Medication includes birth control pill. RN relayed information to PHN who texted medical team. Per medical team, patient is to wait until 28 days post 1st Pfizer dose before receiving Janssen vaccine, it is not recommended to receive Pfizer 2nd dose. Patient was advised to consult with her provider.
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Syncope, Vital signs measurement
Clinical narrative: Patient was vaccinated on 3/12021 with 1st dose Pfizer, lot EN6205 expiration date 6/30/2021. Patient denied medical conditions excpet adverse reaction of seizure after HPV vaccine. Patient informed RN that she had syncopal episode at 15min and 25min after receiving the 1st dose. Her vital signs were within normal limits after. Patient denied allergies. Medication includes birth control pill. RN relayed information to PHN who texted medical team. Per medical team, patient is to wait until 28 days post 1st Pfizer dose before receiving Janssen vaccine, it is not recommended to receive Pfizer 2nd dose. Patient was advised to consult with her provider.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus
Clinical narrative: Headache; Fatigue; depersonalization; feeling of mild hallucination/dream-like; Moderate allergic reaction: face and body itching; Moderate allergic reaction: face and body itching; difficulty swallowing; extremely dizzy and spinning sensation; extremely dizzy and spinning sensation; This is a spontaneous report from a contactable other healthcare professional (patient) reported for herself. A 23-year-old female patient (Not Pregnant at the time of vaccination) received first dose of bnt162b2 (Batch/Lot Number: Unknown), via an unspecified route of administration in left arm on 06Mar2021 14:45 as single dose for covid-19 immunization. Medical history included anemia, migraines, asthma, seasonal/pet allergies, polycystic ovaries (PCOS), allergies: Itchiness with prior pain medication all from an unknown date and unknown if ongoing. Concomitant medications included montelukast; cetirizine hydrochloride (ZYRTEC). The patient experienced feeling of mild hallucination/dream-like, moderate allergic reaction: face and body itching, difficulty swallowing, extremely dizzy and spinning sensation, fatigue, depersonalization all on 06Mar2021 14:45, headache on 08Mar2021. The events were reported as non-serious. Therapeutic measures were taken as a result of moderate allergic reaction: face and body itching. The outcome of events was not resolved. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The adverse event result in doctor or other healthcare professional office/clinic visit. diphenhydramine hydrochloride (BENADRYL) and steroid on site for allergic reaction. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19.  Information about batch/lot number has been requested.; Sender's Comments: Based on the available information, the known safety profile and the temporal association of bnt162b2  administration to the events, a possible contribution of the drug to the events cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Depersonalisation/derealisation disorder, Dizziness, Dysphagia, Fatigue, Hallucination
Clinical narrative: Headache; Fatigue; depersonalization; feeling of mild hallucination/dream-like; Moderate allergic reaction: face and body itching; Moderate allergic reaction: face and body itching; difficulty swallowing; extremely dizzy and spinning sensation; extremely dizzy and spinning sensation; This is a spontaneous report from a contactable other healthcare professional (patient) reported for herself. A 23-year-old female patient (Not Pregnant at the time of vaccination) received first dose of bnt162b2 (Batch/Lot Number: Unknown), via an unspecified route of administration in left arm on 06Mar2021 14:45 as single dose for covid-19 immunization. Medical history included anemia, migraines, asthma, seasonal/pet allergies, polycystic ovaries (PCOS), allergies: Itchiness with prior pain medication all from an unknown date and unknown if ongoing. Concomitant medications included montelukast; cetirizine hydrochloride (ZYRTEC). The patient experienced feeling of mild hallucination/dream-like, moderate allergic reaction: face and body itching, difficulty swallowing, extremely dizzy and spinning sensation, fatigue, depersonalization all on 06Mar2021 14:45, headache on 08Mar2021. The events were reported as non-serious. Therapeutic measures were taken as a result of moderate allergic reaction: face and body itching. The outcome of events was not resolved. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The adverse event result in doctor or other healthcare professional office/clinic visit. diphenhydramine hydrochloride (BENADRYL) and steroid on site for allergic reaction. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19.  Information about batch/lot number has been requested.; Sender's Comments: Based on the available information, the known safety profile and the temporal association of bnt162b2  administration to the events, a possible contribution of the drug to the events cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Hypersensitivity, Pruritus, Vertigo
Clinical narrative: Headache; Fatigue; depersonalization; feeling of mild hallucination/dream-like; Moderate allergic reaction: face and body itching; Moderate allergic reaction: face and body itching; difficulty swallowing; extremely dizzy and spinning sensation; extremely dizzy and spinning sensation; This is a spontaneous report from a contactable other healthcare professional (patient) reported for herself. A 23-year-old female patient (Not Pregnant at the time of vaccination) received first dose of bnt162b2 (Batch/Lot Number: Unknown), via an unspecified route of administration in left arm on 06Mar2021 14:45 as single dose for covid-19 immunization. Medical history included anemia, migraines, asthma, seasonal/pet allergies, polycystic ovaries (PCOS), allergies: Itchiness with prior pain medication all from an unknown date and unknown if ongoing. Concomitant medications included montelukast; cetirizine hydrochloride (ZYRTEC). The patient experienced feeling of mild hallucination/dream-like, moderate allergic reaction: face and body itching, difficulty swallowing, extremely dizzy and spinning sensation, fatigue, depersonalization all on 06Mar2021 14:45, headache on 08Mar2021. The events were reported as non-serious. Therapeutic measures were taken as a result of moderate allergic reaction: face and body itching. The outcome of events was not resolved. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The adverse event result in doctor or other healthcare professional office/clinic visit. diphenhydramine hydrochloride (BENADRYL) and steroid on site for allergic reaction. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19.  Information about batch/lot number has been requested.; Sender's Comments: Based on the available information, the known safety profile and the temporal association of bnt162b2  administration to the events, a possible contribution of the drug to the events cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Abnormal dreams, Arthralgia, Dizziness, Feeding disorder
Clinical narrative: Hallucinations; severe abdominal pain; producing yellow bile; severe dizziness; fever; muscle soreness; joint pain; headache; first dose 13Feb2021 - second dose  02Mar2021 which is 17 days; This is a spontaneous report from a contactable consumer (patient).   A 66-year-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in arm left on 02Mar2021 02:15 PM (lot number: EN6202), at the age of 66-year-old, as SINGLE DOSE for COVID-19 immunisation.  Medical history included asthma, no allergies to food or medicine, allergic to dogs, cats, tree pollen, grasses, dust mites, mold, horses. Concomitant medications included fluticasone propionate, salmeterol xinafoate (ADVAIR) taken for an unspecified indication, start and stop date were not reported; azelastine taken for an unspecified indication, start and stop date were not reported; fluticasone propionate (FLONASE) taken for an unspecified indication, start and stop date were not reported; cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported; vitamin d3 taken for an unspecified indication, start and stop date were not reported. The patient received dose 1 on 13Feb2021 01:45 PM on Left arm (lot number: EL9267). The patient did not have COVID prior vaccination. On 03Mar2021 07:00 am, the patient experienced muscle soreness, joint pain and headache. On 04Mar2021, the experienced severe abdominal pain producing yellow bile, severe dizziness with hallucinations and fever. The patient was unable to stand for more than a few minutes for most of that 48 hours. The outcome of the events severe abdominal pain producing yellow bile, severe dizziness with hallucinations and fever was recovered in 06Mar2021; while the other events was recovering. No treatment was received for the events. The patient was not tested for COVID post vaccination.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hallucination, Headache, Myalgia, Sleep disorder
Clinical narrative: Hallucinations; severe abdominal pain; producing yellow bile; severe dizziness; fever; muscle soreness; joint pain; headache; first dose 13Feb2021 - second dose  02Mar2021 which is 17 days; This is a spontaneous report from a contactable consumer (patient).   A 66-year-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in arm left on 02Mar2021 02:15 PM (lot number: EN6202), at the age of 66-year-old, as SINGLE DOSE for COVID-19 immunisation.  Medical history included asthma, no allergies to food or medicine, allergic to dogs, cats, tree pollen, grasses, dust mites, mold, horses. Concomitant medications included fluticasone propionate, salmeterol xinafoate (ADVAIR) taken for an unspecified indication, start and stop date were not reported; azelastine taken for an unspecified indication, start and stop date were not reported; fluticasone propionate (FLONASE) taken for an unspecified indication, start and stop date were not reported; cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported; vitamin d3 taken for an unspecified indication, start and stop date were not reported. The patient received dose 1 on 13Feb2021 01:45 PM on Left arm (lot number: EL9267). The patient did not have COVID prior vaccination. On 03Mar2021 07:00 am, the patient experienced muscle soreness, joint pain and headache. On 04Mar2021, the experienced severe abdominal pain producing yellow bile, severe dizziness with hallucinations and fever. The patient was unable to stand for more than a few minutes for most of that 48 hours. The outcome of the events severe abdominal pain producing yellow bile, severe dizziness with hallucinations and fever was recovered in 06Mar2021; while the other events was recovering. No treatment was received for the events. The patient was not tested for COVID post vaccination.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Arthralgia, Dizziness, Hallucination, Headache
Clinical narrative: Hallucinations; severe abdominal pain; producing yellow bile; severe dizziness; fever; muscle soreness; joint pain; headache; first dose 13Feb2021 - second dose  02Mar2021 which is 17 days; This is a spontaneous report from a contactable consumer (patient).   A 66-year-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in arm left on 02Mar2021 02:15 PM (lot number: EN6202), at the age of 66-year-old, as SINGLE DOSE for COVID-19 immunisation.  Medical history included asthma, no allergies to food or medicine, allergic to dogs, cats, tree pollen, grasses, dust mites, mold, horses. Concomitant medications included fluticasone propionate, salmeterol xinafoate (ADVAIR) taken for an unspecified indication, start and stop date were not reported; azelastine taken for an unspecified indication, start and stop date were not reported; fluticasone propionate (FLONASE) taken for an unspecified indication, start and stop date were not reported; cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported; vitamin d3 taken for an unspecified indication, start and stop date were not reported. The patient received dose 1 on 13Feb2021 01:45 PM on Left arm (lot number: EL9267). The patient did not have COVID prior vaccination. On 03Mar2021 07:00 am, the patient experienced muscle soreness, joint pain and headache. On 04Mar2021, the experienced severe abdominal pain producing yellow bile, severe dizziness with hallucinations and fever. The patient was unable to stand for more than a few minutes for most of that 48 hours. The outcome of the events severe abdominal pain producing yellow bile, severe dizziness with hallucinations and fever was recovered in 06Mar2021; while the other events was recovering. No treatment was received for the events. The patient was not tested for COVID post vaccination.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Inappropriate schedule of product administration, Myalgia, Pyrexia, Vomiting
Clinical narrative: Hallucinations; severe abdominal pain; producing yellow bile; severe dizziness; fever; muscle soreness; joint pain; headache; first dose 13Feb2021 - second dose  02Mar2021 which is 17 days; This is a spontaneous report from a contactable consumer (patient).   A 66-year-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in arm left on 02Mar2021 02:15 PM (lot number: EN6202), at the age of 66-year-old, as SINGLE DOSE for COVID-19 immunisation.  Medical history included asthma, no allergies to food or medicine, allergic to dogs, cats, tree pollen, grasses, dust mites, mold, horses. Concomitant medications included fluticasone propionate, salmeterol xinafoate (ADVAIR) taken for an unspecified indication, start and stop date were not reported; azelastine taken for an unspecified indication, start and stop date were not reported; fluticasone propionate (FLONASE) taken for an unspecified indication, start and stop date were not reported; cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported; vitamin d3 taken for an unspecified indication, start and stop date were not reported. The patient received dose 1 on 13Feb2021 01:45 PM on Left arm (lot number: EL9267). The patient did not have COVID prior vaccination. On 03Mar2021 07:00 am, the patient experienced muscle soreness, joint pain and headache. On 04Mar2021, the experienced severe abdominal pain producing yellow bile, severe dizziness with hallucinations and fever. The patient was unable to stand for more than a few minutes for most of that 48 hours. The outcome of the events severe abdominal pain producing yellow bile, severe dizziness with hallucinations and fever was recovered in 06Mar2021; while the other events was recovering. No treatment was received for the events. The patient was not tested for COVID post vaccination.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Hyperhidrosis, Immediate post-injection reaction, Tremor
Clinical narrative: about a minute after injection, started shaking, sweating, got very light headed with the feeling I might pass out. Chest got very tight and breathing was strained. Waited with a pharmacy tech, drank water, called husband to come pick me up. Blood pressure went to 178/110, heart rate up to 154 before it subsided. Was able to leave after 45 minutes. Took Benadryl for the next 48 hours to stop reaction. Had waves of the same symptoms several times a day for 4 days after injection.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Dizziness, Dyspnoea, Hyperhidrosis, Presyncope
Clinical narrative: about a minute after injection, started shaking, sweating, got very light headed with the feeling I might pass out. Chest got very tight and breathing was strained. Waited with a pharmacy tech, drank water, called husband to come pick me up. Blood pressure went to 178/110, heart rate up to 154 before it subsided. Was able to leave after 45 minutes. Took Benadryl for the next 48 hours to stop reaction. Had waves of the same symptoms several times a day for 4 days after injection.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tremor
Clinical narrative: about a minute after injection, started shaking, sweating, got very light headed with the feeling I might pass out. Chest got very tight and breathing was strained. Waited with a pharmacy tech, drank water, called husband to come pick me up. Blood pressure went to 178/110, heart rate up to 154 before it subsided. Was able to leave after 45 minutes. Took Benadryl for the next 48 hours to stop reaction. Had waves of the same symptoms several times a day for 4 days after injection.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Patient received wrong second dose. First dose was Moderna, second dose was Pfizer.
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Fall, Feeling abnormal, Head injury, Seizure
Clinical narrative: 0 3/12/2021 pt had a seizure. 03/13/2021 pt had multiple seizures. Pt was admitted to facility
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electroencephalogram, Partial seizures, Seizure
Clinical narrative: 0 3/12/2021 pt had a seizure. 03/13/2021 pt had multiple seizures. Pt was admitted to facility
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Paraesthesia, Paraesthesia oral
Clinical narrative: 79 year old Female  received the 1st dose of the Moderna COVID-19 Vaccine Lot# 030A21A on 03/12/2021 @ 09:40. Pt was placed in observation for 30 minutes and then released. On the drive home pt felt tightness in the chest, chest pain, roof of mouth was swelling and burning, severe itching on the arm, (shortness of breath was experienced while walking to the car), and immediately drove to ED. Pt was admitted to the ED 03/12/2021 @ 11:00 and was discharged 03/12/2021 @ 12:30. Pt was given Prednisone, Benedryl, Pepcid, Potassium, and Clonidine in the ED. Upon discharge, pt was advised by the ED to come back if symptoms come back/worsen, make an appointment with primary doctor, and was given a prescription for Prednisone and Atarax (hydroxyzine) 25mg. Morning of 03/13/2021 pt reported throat was narrowing, dificulty swallowing, lips feeling tingly, and shortness of breath when normally walking down the hall. Pt went to ED , was admitted 03/13/2021 @ 12:00 and discharged same day 03/13/2021 @ 17:00. Pt takes Amlodipine 5mg qd, Levothyroxine 25mcg qd, Losartan 50mg bid, Furosemide 40mg qd, Diltiazem 120 mg qd, Tizanidine 2mg qhs, Anatrozole 1mg qd, Venlofaxine ER 37.5mg qd, Clonidine 0.1mg (PRN when SBP > 170), K 20 mEq, Folic Acid, B12, Homocysteine Factor, IBU (PRN for discomfort), and Cetirizine. Pt is diagnosed with osteoarthritis, obstructive sleep apnea, degenerative joint disease, degenerative dsic disease, scoliosis, hypertension, cardiac arrhythmia, hypothyroidism, breast cancer remission (5 years of remission on the left breast and 4 years of remission on the right breast). Pt is allergic to Sulfa drugs, Nitrofurantoin (Macrobid), and Prempro. Pt made an appointment with the primary doctor for 04/01/2021 and the cardiologist appointment is scheduled for 04/22/2021. Pt was advised to call cardiologist and move the appointment to the next availability, consult primary doctor and cardiologist to see if it is advised to received the second dose and abide by their recommendation, and immediately go to the ED for for any symptoms/side-effects. SPI was consulted and Dr was notified.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chest pain, Dysphagia, Dyspnoea, Oral discomfort
Clinical narrative: 79 year old Female  received the 1st dose of the Moderna COVID-19 Vaccine Lot# 030A21A on 03/12/2021 @ 09:40. Pt was placed in observation for 30 minutes and then released. On the drive home pt felt tightness in the chest, chest pain, roof of mouth was swelling and burning, severe itching on the arm, (shortness of breath was experienced while walking to the car), and immediately drove to ED. Pt was admitted to the ED 03/12/2021 @ 11:00 and was discharged 03/12/2021 @ 12:30. Pt was given Prednisone, Benedryl, Pepcid, Potassium, and Clonidine in the ED. Upon discharge, pt was advised by the ED to come back if symptoms come back/worsen, make an appointment with primary doctor, and was given a prescription for Prednisone and Atarax (hydroxyzine) 25mg. Morning of 03/13/2021 pt reported throat was narrowing, dificulty swallowing, lips feeling tingly, and shortness of breath when normally walking down the hall. Pt went to ED , was admitted 03/13/2021 @ 12:00 and discharged same day 03/13/2021 @ 17:00. Pt takes Amlodipine 5mg qd, Levothyroxine 25mcg qd, Losartan 50mg bid, Furosemide 40mg qd, Diltiazem 120 mg qd, Tizanidine 2mg qhs, Anatrozole 1mg qd, Venlofaxine ER 37.5mg qd, Clonidine 0.1mg (PRN when SBP > 170), K 20 mEq, Folic Acid, B12, Homocysteine Factor, IBU (PRN for discomfort), and Cetirizine. Pt is diagnosed with osteoarthritis, obstructive sleep apnea, degenerative joint disease, degenerative dsic disease, scoliosis, hypertension, cardiac arrhythmia, hypothyroidism, breast cancer remission (5 years of remission on the left breast and 4 years of remission on the right breast). Pt is allergic to Sulfa drugs, Nitrofurantoin (Macrobid), and Prempro. Pt made an appointment with the primary doctor for 04/01/2021 and the cardiologist appointment is scheduled for 04/22/2021. Pt was advised to call cardiologist and move the appointment to the next availability, consult primary doctor and cardiologist to see if it is advised to received the second dose and abide by their recommendation, and immediately go to the ED for for any symptoms/side-effects. SPI was consulted and Dr was notified.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palatal swelling, Paraesthesia oral, Pruritus, Throat tightness
Clinical narrative: 79 year old Female  received the 1st dose of the Moderna COVID-19 Vaccine Lot# 030A21A on 03/12/2021 @ 09:40. Pt was placed in observation for 30 minutes and then released. On the drive home pt felt tightness in the chest, chest pain, roof of mouth was swelling and burning, severe itching on the arm, (shortness of breath was experienced while walking to the car), and immediately drove to ED. Pt was admitted to the ED 03/12/2021 @ 11:00 and was discharged 03/12/2021 @ 12:30. Pt was given Prednisone, Benedryl, Pepcid, Potassium, and Clonidine in the ED. Upon discharge, pt was advised by the ED to come back if symptoms come back/worsen, make an appointment with primary doctor, and was given a prescription for Prednisone and Atarax (hydroxyzine) 25mg. Morning of 03/13/2021 pt reported throat was narrowing, dificulty swallowing, lips feeling tingly, and shortness of breath when normally walking down the hall. Pt went to ED , was admitted 03/13/2021 @ 12:00 and discharged same day 03/13/2021 @ 17:00. Pt takes Amlodipine 5mg qd, Levothyroxine 25mcg qd, Losartan 50mg bid, Furosemide 40mg qd, Diltiazem 120 mg qd, Tizanidine 2mg qhs, Anatrozole 1mg qd, Venlofaxine ER 37.5mg qd, Clonidine 0.1mg (PRN when SBP > 170), K 20 mEq, Folic Acid, B12, Homocysteine Factor, IBU (PRN for discomfort), and Cetirizine. Pt is diagnosed with osteoarthritis, obstructive sleep apnea, degenerative joint disease, degenerative dsic disease, scoliosis, hypertension, cardiac arrhythmia, hypothyroidism, breast cancer remission (5 years of remission on the left breast and 4 years of remission on the right breast). Pt is allergic to Sulfa drugs, Nitrofurantoin (Macrobid), and Prempro. Pt made an appointment with the primary doctor for 04/01/2021 and the cardiologist appointment is scheduled for 04/22/2021. Pt was advised to call cardiologist and move the appointment to the next availability, consult primary doctor and cardiologist to see if it is advised to received the second dose and abide by their recommendation, and immediately go to the ED for for any symptoms/side-effects. SPI was consulted and Dr was notified.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blindness unilateral, Retinal artery occlusion, Vision blurred, Vitreous floaters
Clinical narrative: Branch retinal artery occlusions in right eye on 3/6/2021, followed by central retinal artery occlusion in left eye on 3/7/2021.  Vision reduced to 20/40 and 20/200
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Blindness unilateral, Pruritus, Pyrexia, Retinal artery occlusion
Clinical narrative: Branch retinal artery occlusions in right eye on 3/6/2021, followed by central retinal artery occlusion in left eye on 3/7/2021.  Vision reduced to 20/40 and 20/200
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fluorescence angiogram abnormal, Optical coherence tomography abnormal, Retinal artery occlusion, Visual impairment
Clinical narrative: Branch retinal artery occlusions in right eye on 3/6/2021, followed by central retinal artery occlusion in left eye on 3/7/2021.  Vision reduced to 20/40 and 20/200
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Nausea, Tachycardia
Clinical narrative: Got hot, felt nauseated, fast heart rate  and a little light headed and dizzy I also did not eat before i got the shot they seem to think my sugar dropped as soon as i had  something  to eat and drink i was fine
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Feeling hot, Heart rate increased, Nausea
Clinical narrative: Got hot, felt nauseated, fast heart rate  and a little light headed and dizzy I also did not eat before i got the shot they seem to think my sugar dropped as soon as i had  something  to eat and drink i was fine
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Eye pain, Feeling hot, Ocular discomfort, Ocular hyperaemia
Clinical narrative: diagnosed acute right eye scleritis; Rash on face, neck, chest, arms, hands; flushed in the face; itchy all over the body; hot all over within 45 minutes of the shot administration; This is a spontaneous report from a contactable consumer reported for herself. A 50-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in left arm on 25Feb2021 13:00 (Lot Number: EL9266, at age of 50-year-old) at single dose for covid-19 immunization. The COVID-19 vaccine was administered at facility of workplace clinic. Medical history included hashimotos thyroiditis, allergies to sulfa, penicillin, latex. The patient is not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication with in 2 weeks of vaccination included thyroid (THYROID). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Feb2021 at 13:45, the patient experienced rash on face, neck, chest, arms, hands, flushed in the face, itchy all over the body, hot all over within 45 minutes of the shot administration. Diphenhydramine hydrochloride (BENADRYL) was required for 36 hours to mitigate the reaction. Then on 01Mar2021, right eye developed increased pressure, pain, inflamed blood vessels, severe photosensitivity. At emergent eye doctor appointment, the patient was diagnosed acute right eye scleritis. Treatment for the events included diphenhydramine hydrochloride, steroid eye drop, antiinflammation meds. The events were non-serious per reporter. The events result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The outcome of the events was unknown.   Follow up attempts are needed. Further information has been requested.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Photophobia, Pruritus, Rash macular, Scleritis
Clinical narrative: diagnosed acute right eye scleritis; Rash on face, neck, chest, arms, hands; flushed in the face; itchy all over the body; hot all over within 45 minutes of the shot administration; This is a spontaneous report from a contactable consumer reported for herself. A 50-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in left arm on 25Feb2021 13:00 (Lot Number: EL9266, at age of 50-year-old) at single dose for covid-19 immunization. The COVID-19 vaccine was administered at facility of workplace clinic. Medical history included hashimotos thyroiditis, allergies to sulfa, penicillin, latex. The patient is not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication with in 2 weeks of vaccination included thyroid (THYROID). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Feb2021 at 13:45, the patient experienced rash on face, neck, chest, arms, hands, flushed in the face, itchy all over the body, hot all over within 45 minutes of the shot administration. Diphenhydramine hydrochloride (BENADRYL) was required for 36 hours to mitigate the reaction. Then on 01Mar2021, right eye developed increased pressure, pain, inflamed blood vessels, severe photosensitivity. At emergent eye doctor appointment, the patient was diagnosed acute right eye scleritis. Treatment for the events included diphenhydramine hydrochloride, steroid eye drop, antiinflammation meds. The events were non-serious per reporter. The events result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The outcome of the events was unknown.   Follow up attempts are needed. Further information has been requested.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling hot, Flushing, Pruritus, Rash, Scleritis
Clinical narrative: diagnosed acute right eye scleritis; Rash on face, neck, chest, arms, hands; flushed in the face; itchy all over the body; hot all over within 45 minutes of the shot administration; This is a spontaneous report from a contactable consumer reported for herself. A 50-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in left arm on 25Feb2021 13:00 (Lot Number: EL9266, at age of 50-year-old) at single dose for covid-19 immunization. The COVID-19 vaccine was administered at facility of workplace clinic. Medical history included hashimotos thyroiditis, allergies to sulfa, penicillin, latex. The patient is not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication with in 2 weeks of vaccination included thyroid (THYROID). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Feb2021 at 13:45, the patient experienced rash on face, neck, chest, arms, hands, flushed in the face, itchy all over the body, hot all over within 45 minutes of the shot administration. Diphenhydramine hydrochloride (BENADRYL) was required for 36 hours to mitigate the reaction. Then on 01Mar2021, right eye developed increased pressure, pain, inflamed blood vessels, severe photosensitivity. At emergent eye doctor appointment, the patient was diagnosed acute right eye scleritis. Treatment for the events included diphenhydramine hydrochloride, steroid eye drop, antiinflammation meds. The events were non-serious per reporter. The events result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The outcome of the events was unknown.   Follow up attempts are needed. Further information has been requested.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Throat irritation
Clinical narrative: About 12 hours in: strong metallic taste About 20 hours in: itchy throat and neck About 24 hours in: difficulty taking a deep breath with minor wheezing
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Dyspnoea, Throat irritation, Wheezing
Clinical narrative: About 12 hours in: strong metallic taste About 20 hours in: itchy throat and neck About 24 hours in: difficulty taking a deep breath with minor wheezing
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Atrioventricular block, Catheterisation cardiac abnormal, Chest discomfort, Echocardiogram normal, Electrocardiogram abnormal
Clinical narrative: Pt seen in ED 2 days after vaccine administration with chest pain, possible NSTEMI with transfer to hospital with cardiac capabilities
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypertension, Myocardial infarction, Myocardial necrosis marker increased
Clinical narrative: Pt seen in ED 2 days after vaccine administration with chest pain, possible NSTEMI with transfer to hospital with cardiac capabilities
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Catheterisation cardiac, Chest pain
Clinical narrative: Pt seen in ED 2 days after vaccine administration with chest pain, possible NSTEMI with transfer to hospital with cardiac capabilities
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Mouth swelling, Pharyngeal swelling, Pruritus, Swollen tongue
Clinical narrative: Patient reports facial itching 5 minutes after vaccination.  Benadryl given at 10:39am.  Patient reports having to "concentrate to swallow".  Epi Pen administered at 11:06am.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphagia, Pruritus
Clinical narrative: Patient reports facial itching 5 minutes after vaccination.  Benadryl given at 10:39am.  Patient reports having to "concentrate to swallow".  Epi Pen administered at 11:06am.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Underdose
Clinical narrative: The shot was administrated, right after, the nurse determined their was air injected and the vaccine did not work.  The nurse communicated to the director about it and they decided to give me a second shot, which determined the same thing.    They said, they could not give me a third, because they don't know what will happen.  They gave me the name of the director and said, they need to look into the next step.  The nurse told me to contact my doctor. They still gave me a vaccination card that the shot was administrated to me.  It doesn't make sense to give me the card stating I received the shot, if the nurse was 99% sure it did not work.  I strongly feel that the clinic did not handle this situation correctly.  They should have never gave me a second and the director should have come over to me to explains.  As a patient you think they know the protocol, but I was in shock and wasn't sure what to do .  After speaking with nurses that I know, they were extremely shocked on how this situation was handled.  This is a pandemic shot, not something to mess around with.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Extra dose administered, Product administration error
Clinical narrative: The shot was administrated, right after, the nurse determined their was air injected and the vaccine did not work.  The nurse communicated to the director about it and they decided to give me a second shot, which determined the same thing.    They said, they could not give me a third, because they don't know what will happen.  They gave me the name of the director and said, they need to look into the next step.  The nurse told me to contact my doctor. They still gave me a vaccination card that the shot was administrated to me.  It doesn't make sense to give me the card stating I received the shot, if the nurse was 99% sure it did not work.  I strongly feel that the clinic did not handle this situation correctly.  They should have never gave me a second and the director should have come over to me to explains.  As a patient you think they know the protocol, but I was in shock and wasn't sure what to do .  After speaking with nurses that I know, they were extremely shocked on how this situation was handled.  This is a pandemic shot, not something to mess around with.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Extra dose administered, HIV infection, Hepatitis, Product administration error
Clinical narrative: The shot was administrated, right after, the nurse determined their was air injected and the vaccine did not work.  The nurse communicated to the director about it and they decided to give me a second shot, which determined the same thing.    They said, they could not give me a third, because they don't know what will happen.  They gave me the name of the director and said, they need to look into the next step.  The nurse told me to contact my doctor. They still gave me a vaccination card that the shot was administrated to me.  It doesn't make sense to give me the card stating I received the shot, if the nurse was 99% sure it did not work.  I strongly feel that the clinic did not handle this situation correctly.  They should have never gave me a second and the director should have come over to me to explains.  As a patient you think they know the protocol, but I was in shock and wasn't sure what to do .  After speaking with nurses that I know, they were extremely shocked on how this situation was handled.  This is a pandemic shot, not something to mess around with.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Immunisation, Syringe issue
Clinical narrative: The shot was administrated, right after, the nurse determined their was air injected and the vaccine did not work.  The nurse communicated to the director about it and they decided to give me a second shot, which determined the same thing.    They said, they could not give me a third, because they don't know what will happen.  They gave me the name of the director and said, they need to look into the next step.  The nurse told me to contact my doctor. They still gave me a vaccination card that the shot was administrated to me.  It doesn't make sense to give me the card stating I received the shot, if the nurse was 99% sure it did not work.  I strongly feel that the clinic did not handle this situation correctly.  They should have never gave me a second and the director should have come over to me to explains.  As a patient you think they know the protocol, but I was in shock and wasn't sure what to do .  After speaking with nurses that I know, they were extremely shocked on how this situation was handled.  This is a pandemic shot, not something to mess around with.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cold sweat, Dizziness, Fall, Loss of consciousness, Peripheral coldness
Clinical narrative: near immediate cold sensation in left arm, nausea, and light headedness  approx 3-5 minutes later hearing loss and blacked out
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Deafness, Dizziness, Feeling cold, Loss of consciousness, Nausea
Clinical narrative: near immediate cold sensation in left arm, nausea, and light headedness  approx 3-5 minutes later hearing loss and blacked out
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Tinnitus
Clinical narrative: Patient described onset of ringing in the ears with intense headache beginning Sunday 3/21 in the afternoon and lasting until Tuesday 3/23 - Since Tuesday the ringing and headache has been episodic.  Today (3/24) patient reports tingling, pins and needles on head/face and neck. Patient says he  has normal sensation in those areas as well.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Paraesthesia, Tinnitus
Clinical narrative: Patient described onset of ringing in the ears with intense headache beginning Sunday 3/21 in the afternoon and lasting until Tuesday 3/23 - Since Tuesday the ringing and headache has been episodic.  Today (3/24) patient reports tingling, pins and needles on head/face and neck. Patient says he  has normal sensation in those areas as well.
Age: 69.0
Sex: M
Vaccine: COVID19, UNK, COVID19, COVID19
Symptoms: Asthenia, Respiratory failure
Clinical narrative: WEAKNESS - GENERALIZED HYPOTENSION Respiratory failure (CMS/HCC)
Age: 69.0
Sex: M
Vaccine: COVID19, UNK, COVID19, COVID19
Symptoms: Asthenia, Hypotension, Respiratory failure
Clinical narrative: WEAKNESS - GENERALIZED HYPOTENSION Respiratory failure (CMS/HCC)
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac arrest, Dyspepsia, Influenza virus test negative, Pulseless electrical activity, Respiration abnormal
Clinical narrative: V-Fib, cardiac arrest Narrative:  First COVID vaccine administered 2/25/21 with no noted reaction. Patient received his second COVID vaccine 3/21/21 at 1203. Notes in electronic medical record indicate in the morning of 3/22/21 he arrived at a hospital with ER this morning in V-Fib/cardiac arrest. Unclear of potential treatment that was administered at outside facility. Time of Death was about 1330 on 3/22/21.